A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients. [electronic resource]
Producer: 20060731Description: 309-20 p. digitalISSN:- 1352-4585
- Adult
- Disability Evaluation
- Female
- Follow-Up Studies
- Glatiramer Acetate
- Humans
- Immunologic Factors -- administration & dosage
- Immunosuppressive Agents -- administration & dosage
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Patient Dropouts
- Peptides -- administration & dosage
- Prospective Studies
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.